Finland· FI-REL-REL1150

Indalgin

A indometacin, kombinationen product containing indometacin + ethylmorphine hydrochloride, registered in Finland by Orion Corporation Orion Pharma.

ATC M01AB51

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedIndalginATCM01AB51REGISTER NO.FI-REL-REL1150PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Indometacin + Ethylmorphine hydrochloride
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
M01AB51
ATC class
Indometacin, Kombinationen
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6e35f0d-ca91-4e14-a099-e21d4e3220af
GET /v1/drugs/e6e35f0d-ca91-4e14-a099-e21d4e3220af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "3",
  "form": "kapseli, kova",
  "route": null,
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "indometasiini, yhdistelmävalmisteet",
  "ma_number": "7404",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1150",
  "authorised_at": "1977-04-20"
}

See everything about indometacin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.